Results 71 to 80 of about 16,115 (202)
Journal of Neuroendocrinology, Volume 38, Issue 10, October 2026.Abstract Prolactinomas in the transition age present unique challenges; treatment strategies and long‐term outcomes in this population remain incompletely characterised. This is a multicentre, retrospective study of 110 consecutive patients (33 males) with prolactinomas, aged 15–25 years, across five Italian referral centres (2010–2025).
Dario De Alcubierre +17 more
wiley +1 more source
Symptoms of hyperprolactinemia with normal serum prolactin: is treatment required? [PDF]
, 2017 Galactorrhea with menstrual abnormalities like oligomenorrhea or amenorrhea point towards a provisional diagnosis of increased serum prolactin levels or hyperprolactinemia.
Verma, Deepti
core +1 more source
Penfluridol Triggers GSDME‐Mediated Immunogenic Pyroptosis to Potentiate Antitumor Immunotherapy
Advanced Science, Volume 13, Issue 54, 28 September 2026.A high‐throughput screen of FDA‐approved antipsychotics identifies penfluridol as a potent pyroptosis inducer acting via direct TTI1 inhibition. This triggers TNFA‐NFKB signaling and caspase‐8/‐3‐dependent GSDME cleavage. The compound stimulates antitumor immunity alone and synergizes with anti‐PD‐1 therapy, while low TTI1 expression emerges as a ...
Linfeng Li +11 more
wiley +1 more source
Menstrual disorders associated with hyperprolactinemia
, 1985 In hyperprolactinemia, menstrual disorders ranging from irregular bleeding, insufficient luteal phase, spanio-amenorrhea, to anovulatory cycles and amenorrhea, are frequent.
Caufriez, Anne
core
Anais da Faculdade de Medicina de Olinda, 2018 Objective: To evaluate the importance of screening for macroprolactin in symptomatic patients with apparent idiopathic hyperprolactinemia. Methods: During 20 months, the prevalence of macroprolactinemia was evaluated among consecutive symptomatic female
Lucio Vilar +11 more
doaj +1 more source
Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center
The Pan African Medical Journal, 2020 Macroprolactinemia frequently causes misdiagnosis, unnecessary investigation and inappropriate treatment in hyperprolactinemic patients. Aim of this study is to investigate the prevalence and clinical characteristics of Thai patients with ...
Phronpan Chutpiboonwat +5 more
doaj +1 more source
Hyperprolactinemia With Aripiprazole
, 2014 Aripiprazole, due to its partial agonist activity at the D2 receptors, is often recommended as the drug of choice in patients who develop antipsychotic-induced hyperprolactinemia.
Behere, Rishikesh V. +5 more
core +1 more source
Development of Hyperprolactinemia Induced by the Addition of Bupropion to Venlafaxine XR Treatment
Bezmiâlem Science, 2018 Hyperprolactinemia is characterized by abnormally increased serum prolactin levels. Menstrual irregularities and hyperprolactinemia can be caused by a variety of medical conditions as well as due to the use of some psychopharmacological drugs, namely ...
Alperen KILIÇ +3 more
doaj +1 more source
Retrospective Analysis of Cushing’s Disease with or without Hyperprolactinemia
International Journal of Endocrinology, 2014 Objective. We compared the characteristics of patients with Cushing’s disease alone with those of patients with Cushing’s disease and hyperprolactinemia. Methods. Eighty-four patients were enrolled between 2002 and 2011, in a hospital in China. Clinical,
Cheng Huan +4 more
doaj +1 more source
Psychiatry and Behavioral Sciences, 2017 Hyperprolactinemia is a severe problem which involves galactorrhea, amenorrhea, sexual dysfunction, and lowered bone mineral density. It can be a long-lasting problem belongs to the atypical antipsychotics that impairs treatment adherence and quality of ...
Orkun Aydin, Pinar Unal-Aydin
doaj +1 more source